Glycolipid-activated NKT cells support the induction of persistent plasma cell responses and antibody titers

European Journal of Immunology

Volumn 38, Issue 4, 2008, Pages 1001-1011

  Devera, T Scott ^a   Shah, Hemangi B ^a   Lang, Gillian A ^a   Lang, Mark L ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Antibodies; B cells; NKT cells; Transgenic knockout mice

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; ALUMINUM POTASSIUM SULFATE; CD1D ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G2C; INTERLEUKIN 4; KEYHOLE LIMPET HEMOCYANIN; NITROPHENOL; RECEPTOR BLOCKING AGENT; THYMUS DEPENDENT ANTIGEN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; ANTIBODY; CD1 ANTIGEN; GLYCOLIPID; LIGAND;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BONE MARROW CELL; C57BL 6 MOUSE; CD1D MOUSE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; FEMALE; HUMORAL IMMUNITY; MOUSE; MOUSE STRAIN; NATURAL KILLER T CELL; NONHUMAN; PERSISTENT PLASMA CELL RESPONSE; PLASMA CELL; PRIORITY JOURNAL; SPLEEN; TH1 CELL; TH2 CELL; ANIMAL; ANTIBODY PRODUCTION; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; REGULATORY T LYMPHOCYTE; TITRIMETRY;

ANIMALS; ANTIBODIES; ANTIBODY FORMATION; ANTIGENS, CD1; CELL DIFFERENTIATION; FEMALE; GLYCOLIPIDS; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLASMA CELLS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TITRIMETRY; TOLL-LIKE RECEPTORS;

EID: 44849131118     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200738000     Document Type: Article

References (44)

1. Porcelli, S. A. and Modlin, R. L., The CD1 system: Antigen-presenting molecules for T cell recognition of lipids and glycolipids, Annu. Rev. Immunol. 1999. 17: 297-329.
2. Godfrey, D. I., MacDonald, H. R. Kronenberg, M., Smyth, M. J. and Van Kaer, L., NKT cells: What's in a name? Nat. Rev. Immunol., 4: 231-237
3. Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J. and Baxter, A. G., NKT cells: Facts, functions and fallacies. Immunol. Today 2000. 21: 573-583.
4. Singh, N., Hong, S., Scherer, D. C., Serizawa, I., Burdin, N., Kronenberg, M., Koezuka, Y. and Van Kaer, L., Cutting edge: Activation of NK T cells by CD1d and alpha galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J. Immunol. 1999. 163: 273-2377.
5. Burdin, N., Brossay, I., and Kronenberg, M., Immunization with alpha-galactosylceramide polarizes CD1 reactive NK T cells towards Th2 cytokine synthesis. Eur. J. Immunol. 1999. 29: 2014-2025.
6. Cut, J., Watanabe, N., Kawano, t., Yamashita, M., Kamata, T., Shimizu, C., Kimura, M. et al., Inhibition of T helper cell type 2 cell differentiation and immunolobulin E response by ligand-activated Valpha14 natural killer T cells. J. Exp. Med. 1999. 190: 783-792.
7. Giaccone, G., Punt, C. J., Ando, Y., Ruijter, R., Nishi, N., Peters, M., von Blomberg, B. M. et al., A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. Clin. Cancer Res. 2002. 8: 3702-3709.
8. Ishikawa, A., Motohashi, S., Ishikawa, E., Fuchida, H., Higashino, K., Otsuji, M., Iizasa, T. et al., A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer. Clin. Cancer Res. 2005. 11: 1910-1917.
9. Campos, R. A., Szczepanik, M., Itakura, A., Akahira-Azuma, M., Sidobre, S., Kronenberg, M. and Askenase, P. W., Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J. Exp. Med. 2003. 198: 1785-1796.
10. Galli, G., Nutí, S., Tavarini, S., Galli-Stampino, L., De Lalla, C., Casorati, G., Dellabona, P. and Abrignani, S., CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J. Exp. Med. 2003. 197: 1051-1057.
11. Kitamura, H., Ohta, A., Sekimoto, M., Sato, M., Iwakabe, K., Nakui, M., Yahata, T. et a., alpha-Galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. Cell. Immunol. 2000. 199: 37-42.
12. Procopio, D. O., Almeida, I. C., Torrecilhas, A. C., Cardoso, J. E., Teyton, L., Travassos, L. R., Bendelac, A. and Gazzinelli, R. T., Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway. J. Immunol. 2002. 169: 3926-3933.
13. Schofield, L., McConville, M. J., Hansen, D., Campbell, A. S., Fraser-Reid, B., Grusby, M. J. and Tachado, S. D., CD1d-restricted immunoglobulin G formation to GP1-anchored antigens mediated by NKT cells. Science 1999. 283: 225-229.
14. + T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice. J. Exp. Med. 2003. 197: 997-1005.
15. Lisbonne, M., Diem, S., de Castro Keller, A., Lefort, J., Araujo, L. M., Hachem, P., Fourneau, J. M. et al., Cutting edge: Invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyper-reactivity in an experimental asthma model. J. Immunol. 2003. 171: 1637-1641.
16. Belperron, A. A., Dailey, C. M. and Bockenstedt, L. K., Infection-induced marginal zone B cell production of Borrelia hermsii-specific antibody is impaired in the absence of CD1d. J. Immunol. 2005. 174: 5681-5686.
17. Kumar, H., Belperron, A., Barthold, S.W. and Bockenstedt, L. K., Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J. Immunol. 2000. 165: 4797-4801.
18. + T cells. J. Immunol. 2005. 174: 1787-1790.
19. Ko, S. Y., Ko, H. J., Chang, W. S., Park, S. H., Kweon, M. N. and Kang, C. Y., Alpha-galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor. J. Immunol. 2005. 175: 3309-3317.
20. Lang, G. A., Exley, M. A. and Lang, M. L., The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner. Immunology 2006. 119: 116-125.
21. Galli, G., Pittoni, P., Tonti, E., Malzone, C., Uematsu, Y., Tortoli, M., Maione, D. et al., Invariant NKT cells sustain specific B cell responses and memory. Proc. Natl. Acad. Sci. USA 2007. 104: 3984-3989.
22. Slifka, M. K., Antia, R., Whitmire, J. K. and Ahmed, R., Humoral immunity due to long-lived plasma cells. Immunity 1998. 8: 363-372.
23. McHeyzer-Williams, L. J. and McHeyzer-Williams, M. G., Antigen-specific memory B cell development. Annu. Rev. Immunol. 2005. 23: 487-513.
24. Ikarashi, Y., Iizuka, A., Koshidaka, Y., Heike, Y., Takaue, Y., Yoshida, M., Kronenberg, M. and Wakasugi, H., Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide. Immunology 2005. 116: 30-37.
25. Wilson, M. T., Johansson, C., Olivares-Villagomez, D., Singh, A. K., Stanic, A. K., Wang, C. R., Joyce, S. et al., The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc. Natl. Acad. Sci. USA 2003. 100: 10913-10918.
26. Crowe, N. Y., Uldrich, A. P., Kyparissoudis, K., Hammond, K. J., Hayakawa, Y., Sidobre, S., Keating, R. et al., Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. J. Immunol. 2003. 171: 4020-4027.
27. Mizuno, M., Masumura, M., Tomi, C., Chiba, A., Oki, S., Yamamura, T. and Miyake, S., Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice. J. Autoimmun. 2004. 23: 293-300.
28. Forestier, C., Takaki, T., Molano, A., Im, J. S., Baine, I., Jerud, E. S., Illarionov, P. et al., Improved outcomes in NOD mice treated with a novel Th2 cytokine-biasing NKT cell activator. J. Immunol. 2007. 178: 1415-1425.
29. Miyamoto, K., Miyake, S. and Yamamura, T., A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001. 413: 531-534.
30. Schmieg, J., Yang, G., Franck, R. W. and Tsuji, M., Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-galactosylceramide. J. Exp. Med. 2003. 198: 1631-1641.
31. Brigl, M., Bry, L., Kent, S. C., Gumperz, J. E. and Brenner, M. B., Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 2003. 4: 1230-1237.
32. Hermans, I. F., Silk, J. D., Gileadi, U., Masri, S.H., Shepherd, D., Farrand, K. J., Salio, M. and Cerundolo, V., Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells. J. Immunol. 2007. 178: 2721-2729.
33. Nagarajan, N. A. and Kronenberg, M., Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J. Immunol. 2007. 178: 2706-2713.
34. Slifka, M. K. and Ahmed, R., Long-lived plasma cells: A mechanism for maintaining persistent antibody production. Curr. Opin. Immunol. 1998. 10: 252-258.
35. + T cells. J. Leukoc. Biol. 2005. 78: 1273-1280.
36. Raman, V. S., Lind, E. F., Benson, M. J. and Noelle, R. J., Strategies for selective priming of memory B cells. Immunol. Lett. 2007. 109: 93-100.
37. Sireci, G., Russo, D., Dieli, F., Porcelli, S. A., Taniguchi,M., La Manna,M. P., Di Liberto, D. et al., Immunoregulatory role of Jalpha281 T cells in aged mice developing lupus-like nephritis. Eur. J. Immunol. 2007. 37: 425-433.
38. Yang, J. Q., Singh, A. K., Wilson, M. T., Satoh, M., Stanic, A. K., Park, J. J., Hong, S. et al., Immunoregulatory role of CD1d in the hydrocarbon oil-induced model of lupus nephritis. J. Immunol. 2003. 171: 2142-2153.
39. Hoyer, B. F., Moser, K., Hauser, A. E., Peddinghaus, A., Voigt, C., Eilat, D., Radbruch, A. et al., Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J. Exp. Med. 2004. 199: 1577-1584.
40. Zhou, D., Mattner, J., Cantu, C. 3rd, Schrantz, N., Yin, N., Gao, Y., Sagiv, Y. et al., Lysosomal glycosphingolipid recognition by NKTcells. Science 2004. 306: 1786-1789.
41. Lang, G. A., Maltsev, S. D., Besra, G. S. and Lang, M. L., Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts. Immunology 2004. 112: 386-396.
42. Exley, M. A., Bigley, N. J., Cheng, O., Shaulov, A., Tahir, S. M., Carter, Q. L., Garcia, J. et al., Innate immune response to encephalomyocarditis virus infection mediated by CD1d. Immunology 2003. 110: 519-526.
43. Pasare, C. and Medzhitov, R., Control of B-cell responses by Toll-like receptors. Nature 2005. 438: 364-368.
44. Gavin, A. L., Hoebe, K., Duong, B., Ota, T., Martin, C., Beutler, B. and Nemazee, D., Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 2006. 314: 1936-1938.